戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 microbiome can be useful as a biotherapy for acne vulgaris.
2 uman skin and can promote the common disease acne vulgaris.
3  all relevant studies of isotretinoin use in acne vulgaris.
4 lighted as a dominant etiological factor for acne vulgaris.
5 be a well-tolerated, effective treatment for acne vulgaris.
6 tion is necessary for treating patients with acne vulgaris.
7 re centrally involved in the pathogenesis of acne vulgaris.
8 d be developed as an effective treatment for acne vulgaris.
9 ising therapeutic agent for the treatment of acne vulgaris.
10 l factor contributing to the pathogenesis of acne vulgaris.
11 s frequently prescribed for the treatment of acne vulgaris.
12 s association with the common teenage malady acne vulgaris.
13 ass antibiotic approved for the treatment of acne vulgaris.
14 ernative treatment for antibiotic therapy of acne vulgaris.
15 volved in the progression of inflammation in acne vulgaris.
16 m acnes is also associated with inflammatory acne vulgaris.
17  contribute to the common human skin disease acne vulgaris.
18 ore than 45 million people are affected with acne vulgaris.
19 nsins may be involved in the pathogenesis of acne vulgaris.
20 velopment of new modalities of treatment for acne vulgaris.
21 en hypothesized to contribute to the disease acne vulgaris.
22 n the overgrowth of C. acnes at the onset of acne vulgaris.
23 ntact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.19% for urticaria,
24 ost common being obesity (263/406 [65%]) and acne vulgaris (118/406 [29%]).
25 in and general medical conditions, including acne vulgaris (558 [51.0%]), acne conglobata (503 [45.9%
26                                              Acne vulgaris (acne) is a common inflammatory disorder o
27  targets of antibiotic-based therapy against acne vulgaris (acne).
28 oneedles for cosmetic applications including acne vulgaris, acne scars, skin rejuvenation and hair gr
29                                              Acne vulgaris affects approximately 9% of the population
30                       The high prevalence of acne vulgaris and its significant morbidity underscore t
31 erium that contributes to the development of acne vulgaris and other infections.
32  search was conducted using the search terms acne vulgaris and rosacea in the following databases: ME
33 otretinoin therapy for conditions other than acne vulgaris, and concomitant acne therapy.
34  plus red light is an effective treatment of acne vulgaris, associated with significant side-effects.
35 ortholog associated with the emergence of an acne vulgaris-associated, pathobiont subspecies.
36                                              Acne vulgaris (AV) affects most adolescents, and of thos
37 reatment by oral isotretinoin in patients of acne vulgaris (AV).
38                               In comparison, acne vulgaris, bacterial skin diseases, urticaria, pruri
39 cently developed to treat moderate to severe acne vulgaris by directly delivering the combination of
40                                              Acne vulgaris can cause permanent physical scarring, neg
41  of the factors that initiate and exacerbate acne vulgaris continues to increase, so does the diversi
42                       The pathophysiology of acne vulgaris depends on active sebaceous glands, implyi
43 athogenesis of many skin conditions, such as acne vulgaris, hirsutism, and androgenic alopecia.
44 vulinic acid was tested for the treatment of acne vulgaris, in an open-label prospective human study.
45                                              Acne vulgaris is a common cutaneous disorder of the pilo
46                                              Acne vulgaris is a common skin condition that affects ap
47                                              Acne vulgaris is a common skin disorder among children a
48                                              Acne vulgaris is a highly heritable skin disorder that p
49                                              Acne vulgaris is a nearly universal cutaneous disease ch
50                                              Acne vulgaris is a nearly universal cutaneous inflammato
51                                              Acne vulgaris is an inflammatory disease of the piloseba
52                                              Acne vulgaris is classified based on patient age, lesion
53                                              Acne vulgaris is the most common skin disorder affecting
54  upregulation of beta-defensin expression in acne vulgaris lesions compared to controls suggests that
55 as in perilesional and intralesional skin of acne vulgaris lesions such as comedones, papules, and pu
56 atologist for a primary initial diagnosis of acne vulgaris or rosacea in 2010.
57        The most prevalent comorbidities were acne vulgaris (pooled proportion, 43%; 95% CI, 21-65), o
58  analyzed resulting data: eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulce
59 ed in the development of inflammation during acne vulgaris remain unclear, microbial agents might pla
60                                              Acne vulgaris remains one of the most common conditions
61 ral minocycline 200mg daily for treatment of acne vulgaris since 16 years old.
62  a critical component in the pathogenesis of acne vulgaris, stimulating the production of various inf
63 tifunctional antimicrobial therapy agent for acne vulgaris treatment; FFAs may provide direct antibac